Official UK procurement notice
Fixed Bed Bioreactor · UK public procurement notice
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionOne-off requirement, for a single fixed-bed bioreactor, for the production of viral vectors for advanced cell and gene therapies using mammalian cell culture.
CPV: Cytometers
The lotProcurement structure
single lot · no lot value publishedLot #1
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 16 Mar 2023, 12:39 GMT
- Last source update
- 16 Mar 2023, 12:39 GMT
- FTS notice number
2023/S 000-007680- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03b368Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This one-off requirement, for a single fixed-bed bioreactor, for the production of viral vectors for advanced cell and gene therapies (using mammalian cell culture), had to be medium-scale, GMP-compatible, and had to be suitable for process development and GMP-compatible clinical manufacturing. The selected instrument had to provide a colonisable surface area for cell growth of 10-30m2 with working media volumes between one and up to four litres, and the possibility of integrated in-line harvest of the product.<br/><br/>Analysis of different suppliers’ instruments, made it clear that there is currently only one suitable instrument to fulfil the requirements of an intermediate-scale fixed-bed bioreactor, noting that the colonisable surface area or potential current competitor’s instruments were unfortunately either too small , or massively too large for the criteria outlined above.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Univercells Technologies S ASME | — | — | Awarded |
Contracts
Contract 007680-2023-1 · Univercells Technologies S ASME
- Signed
- 13 Mar 2023
- Value
- —
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| — | — | — | £171,411 – £171,412 |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtMediation bodyReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- Univercells Technologies S AAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.